LeMaitre Vascular, Inc. LMAT
81.52
0.70
0.87%
as of 25 Sep
- Market cap
- $1.9B
- P/E
- 28.1×
Follow LMAT
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
15.02% | 15.80% | 16.55% | 16.77% | |
| 10.94% | 9.89% | 10.53% | 10.78% | ||
ROIC |
18.95% | 20.90% | 21.93% | 22.67% | |
Return on Tangible Assets |
11.98% | 12.58% | 13.19% | 13.46% | |
Average Days of Receivables |
49.12 | 49.15 | 50.94 | 49.63 | |
Free Cash Flow per Share |
2.92 | 3.29 | 3.47 | 3.23 | |
Free Cash Flow |
66.23 | 74.47 | 79.12 | 73.83 | |
Capital Expenditures |
(7.05) | (6.78) | (8.18) | (9.15) | |
Piotroski F-Score |
5.00 | 6.00 | 6.00 | 7.00 | |
| Other line items | |||||
Cash ROIC |
8.23% | 8.82% | 9.26% | 8.59% | |
Accounts Receivable Turnover |
7.45 | 7.84 | 7.23 | 7.27 | |
Accounts Payable Turnover |
27.34 | 26.29 | 22.25 | 17.45 | |
Inventory Turnover |
1.03 | 1.05 | 1.04 | 1.02 | |
Average Days of Payables |
18.09 | 18.73 | 21.56 | 16.61 | |
Days of Inventory on Hand |
369.52 | 361.71 | 365.27 | 361.80 | |
Tax Rate |
(0.23) | (0.23) | (0.23) | (0.22) | |
Research and Development Expense of Revenue |
5.91% | 5.66% | 5.50% | 5.87% | |
Selling, General and Administrative Expense of Revenue |
39.35% | 38.66% | 38.38% | 37.56% | |
Share Based Compensation of Revenue |
3.10% | 3.14% | 3.07% | 3.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.37 | 1.41 | 1.40 | 1.26 | |
Depreciation/Fixed assets |
0.41 | 0.42 | 0.40 | 0.38 | |
Capex/Depreciation |
(0.64) | (0.60) | (0.72) | (0.80) | |
Revenue per Share |
10.63 | 11.03 | 11.24 | 11.48 | |
Operating CF per Share |
3.23 | 3.59 | 3.83 | 3.63 | |
Capex per Share |
(0.31) | (0.30) | (0.36) | (0.40) | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 | |
Net Profit Margin |
22.14% | 23.13% | 24.35% | 25.02% |
Columns are period end dates